OptiNose Inc. (NASDAQ: OPTN)
$1.16
-0.1100 ( -8.66% ) 1.3M
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
Market Data
Open
$1.16
Previous close
$1.27
Volume
1.3M
Market cap
$130.00M
Day range
$1.14 - $1.26
52 week range
$0.80 - $2.10
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 07, 2024 |
8-k | 8K-related | 14 | Jun 06, 2024 |
8-k | 8K-related | 15 | May 20, 2024 |
10-q | Quarterly Reports | 71 | May 14, 2024 |
8-k | 8K-related | 34 | May 14, 2024 |
8-k | 8K-related | 21 | May 09, 2024 |
def | Proxies and info statements | 7 | Apr 26, 2024 |
8-k | 8K-related | 43 | Apr 25, 2024 |
4 | Insider transactions | 1 | Mar 19, 2024 |
4 | Insider transactions | 1 | Mar 19, 2024 |